Summary
- Current Price
- As of today, COR price is $360.83, up +2.78% on
- Current Price All-Time High
- COR price is currently -4.43% below its historical high of $377.54 set on
- Market Cap
- COR current market cap is $70B, up +47.77% over the past 365 days
- PE Ratio
- COR current PE ratio is 43.40
- Revenue
- COR current annual revenue is $321.33B, up +9.31% year-over-year
- Next Earnings
- The next earnings release for COR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cencora, Inc. |
| Ticker | NYSE: COR |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Country | United States |
| IPO | |
| Indexes | |
| Website | cencora.com |
| Employees | 42,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $360.83 | |
| Price, 1D Change | +2.78% | |
| Market Cap | $70B | |
| TTM Dividend Yield | 0.64% | |
| PE Ratio | 43.40 | |
| Beta | 0.00 | |
| Revenue | $321B | |
| Revenue, 1Y Change | +9.31% | |
| EPS | $7.96 | |
| EPS, 1Y Change | +5.66% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.60 | |
| Next Ex-Dividend | $0.60 | |
| Last Split | 10:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ABC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $7.96 | |
| EPS Estimate | N/A | $17.62 |
| EPS Est. Change | N/A | +121.37% |
| Revenue | $321.33B | |
| Revenue Estimate | N/A | $346.20B |
| Revenue Est. Change | N/A | +7.74% |
| Current Price | $360.83 | |
| Price Target | - | $405.00 |
| Price Tgt. Change | - | +12.24% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.65 | $7.53 | -44.80% | |
| $15.94 | $7.96 | -50.06% | |
| $17.62 | N/A | +121.37% | |
| $19.59 | N/A | +146.07% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $292.66B | $293.96B | +0.45% | |
| $320.99B | $321.33B | +0.11% | |
| $346.20B | N/A | +7.74% | |
| $368.76B | N/A | +14.76% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +47.56% | |
| Price, 3Y | +127.50% | |
| Market Cap, 1Y | +47.77% | |
| Market Cap, 3Y | +118.20% | |
| Revenue, 1Y | +9.31% | |
| Revenue, 3Y | +34.68% | |
| EPS, 1Y | +5.66% | |
| EPS, 3Y | -1.02% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $360.83 | |
| SMA 200 | $316.99 | |
| SMA 200 vs Price | -12.15% | |
| SMA 50 | $347.01 | |
| SMA 50 vs Price | -3.83% | |
| Beta | 0.00 | |
| ATR | $11.44 | |
| 14-Day RSI | 54.26 | |
| 10-Day Volatility | 66.17% | |
| 1-Year Volatility | 25.00% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.60 | |
| Upcoming | $0.60 | |
| Dividend Yield | 0.61% | |
| Total Dividend | $2.20 | |
| $437.08M | ||
| 27.88% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $321.33B | |
| EPS | $7.96 | |
| Gross Profit | $10.43B | |
| Gross Margin | 3.25% | |
| Operating Profit | $3.93B | |
| Operating Margin | 1.22% | |
| Net Income | $1.57B | |
| Net Margin | 0.49% | |
| EBITDA | $4.98B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 4.38 | |
| 0.90 | ||
| 0.52 | ||
| - | ||
| 5 | ||
| 4.96 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 43.40 | |
| 0.21 | ||
| 36.68 | ||
| 15.78 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.51B | |
| $4.39B | ||
| $76.59B | ||
| $52.24B | ||
| $74.84B | ||
| $57.82B | ||
| Total Debt | $9.33B | |
| $371.56M | ||
| $54.72B |
Expenses
| Metric | Date | Value |
|---|---|---|
| $319.78B | ||
| $6.49B | ||
| $310.91B | ||
| $0.00 | ||
| $1.06B | ||
| $0.00 | ||
| $690.52M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $3.88B | ||
| -$4.98B | ||
| $2.25B | ||
| Capex | $667.98M | |
| $3.21B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Morgan Stanley | → | |
| Jefferies | → | |
| B of A Securities | → | |
| Barclays | ||
| Wells Fargo | → | |
| JP Morgan | → | |
| TD Cowen | → | |
| UBS | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
Screeners with COR
FAQ
What is the ticker symbol for Cencora, Inc.?
The ticker symbol for Cencora, Inc. is NYSE:COR
Does Cencora, Inc. pay dividends?
Yes, Cencora, Inc. pays dividends. The last payment was $0.60, with an ex-dividend date on November 14, 2025
What sector is Cencora, Inc. in?
Cencora, Inc. is in the Healthcare sector
What industry is Cencora, Inc. in?
Cencora, Inc. is in the Medical Distribution industry
What country is Cencora, Inc. based in?
Cencora, Inc. is headquartered in United States
When did Cencora, Inc. go public?
Cencora, Inc. initial public offering (IPO) was on April 4, 1995
Is Cencora, Inc. in the S&P 500?
Yes, Cencora, Inc. is included in the S&P 500 index
Is Cencora, Inc. in the NASDAQ 100?
No, Cencora, Inc. is not included in the NASDAQ 100 index
Is Cencora, Inc. in the Dow Jones?
No, Cencora, Inc. is not included in the Dow Jones index
When was Cencora, Inc. last earnings report?
Cencora, Inc.'s most recent earnings report was on February 4, 2026
When does Cencora, Inc. report earnings?
The next expected earnings date for Cencora, Inc. is May 6, 2026
Data Sources & References
- COR Official Website www.cencora.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1140859/000114085926000006/0001140859-26-000006-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1140859/000114085925000131/0001140859-25-000131-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- COR Profile on Yahoo Finance finance.yahoo.com/quote/COR
- COR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cor
